| 6160 | 6.00% | 183.30 | +10.62% | 324,800 | |
| GSK | 5.68% | 1,413.00 | -0.60% | 302,112 | |
| EXEL | 5.46% | 45.07 | +0.58% | 144,456 | |
| ROG | 5.30% | 257.00 | +0.31% | 17,664 | |
| AZN | 5.13% | 10,312.0 | -1.19% | 38,111 | |
| GMAB | 4.91% | 1,420.5 | +1.00% | 23,587 | |
| 4502 | 4.87% | 4,412.0 | +0.85% | 177,100 | |
SpringWorks Therapeutics Inc Ordinary Shares | - | 4.83% | - | - | 113,200 |
| SASY | 4.82% | 83.54 | +0.41% | 53,141 | |
| INCY | 4.28% | 69.01 | -0.33% | 68,157 |
iShares Trust - iShares Genomics Immunology and Healthcare ETF is an exchange traded fund launched by BlackRock, Inc. The fund is managed by BlackRock Fund Advisors. It invests in public equity markets of global region. It invests in stocks of companies operating across health care, health care equipment and services, pharmaceuticals, biotechnology and life sciences sectors. It invests in growth and value stocks of companies across diversified market capitalization. The fund seeks to track the performance of the NYSE FactSet Global Genomics and Immuno Biopharma Index, by using representative sampling technique. iShares Trust - iShares Genomics Immunology and Healthcare ETF was formed on June 11, 2019 and is domiciled in the United States.